Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment    source : Contravir.com    save search
Hepion Pharmaceuticals Receives FDA Orphan Drug Status Designation for Rencofilstat for the Treatment of Hepatocellular Carcinoma
Published: 2022-06-20 (Crawled : 12:20) - contravir.com
HEPA | News | $2.11 -0.09% -0.09% 73K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
treatment fda designation drug
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.